PIK3CA and prostate cancer: In the prostate cancer datasets analyzed, PIK3CA mutation and high-level gene amplification occur in up to 4% and 9% of cases respectively (Tables S1–S3), although high-level amplification has been observed previously in as many as 29% of cases [13].